Full Access
Published Online:1 Apr 2006https://doi.org/10.1176/ajp.154.7.1037b
- Cited by
- Journal of Obsessive-Compulsive and Related Disorders, Vol. 41
- 17 August 2023 | Scientific Reports, Vol. 13, No. 1
- Current Reviews in Clinical and Experimental Pharmacology, Vol. 18, No. 2
- 14 December 2022 | Journal of Psychopharmacology, Vol. 37, No. 1
- 1 April 2023 | Neuropsychiatric Disease and Treatment, Vol. Volume 19
- Heliyon, Vol. 8, No. 12
- 27 January 2022 | Journal of Psychoactive Drugs, Vol. 54, No. 4
- 22 November 2020 | Journal of Psychoactive Drugs, Vol. 53, No. 2
- 1 January 2021 | Porto Biomedical Journal, Vol. 6, No. 1
- Current Psychopharmacology, Vol. 9, No. 2
- Journal of Psychedelic Studies, Vol. 4, No. 2
- 9 February 2015 | Journal of Psychopharmacology, Vol. 29, No. 3
- Therapeutic Drug Monitoring, Vol. 35, No. 4
- 8 December 2010 | Journal of Psychopharmacology, Vol. 25, No. 11
- 26 June 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 39, No. 9
- MARY JO FITZ-GERALD,
M.D. , - HAROLD B. PINKOFSKY,
M.D., PH.D. , - GUY BRANNON,
M.D. , - EVELYN DANDRIDGE,
R.N. , and - ANDREW CALHOUN,
M.D. ,
1 July 1999 | American Journal of Psychiatry, Vol. 156, No. 7- MARY JO FITZ-GERALD,
- HANDAN GUNDUZ,
M.D. , - JOSEPH L. GEORGES,
M.D. , and - STEWART FLEISHMAN,
M.D. ,
1 July 1999 | American Journal of Psychiatry, Vol. 156, No. 7- HANDAN GUNDUZ,
- DANIEL M. PERRINE,
PH.D. ,
1 July 1999 | American Journal of Psychiatry, Vol. 156, No. 7- DANIEL M. PERRINE,